Awarded Contractocds-kuma6s-141500

Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients

In-line with All Wales Medical genomic Service’s (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.

Buyer

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Value

£660,000

Published

15 May 2024

Closes

15 May 2024

Procurement details

Source

Sell2Wales

Region

United Kingdom

Procurement method

Limited

Category

Goods

Contract starts

Not provided

Contract ends

Not provided

CPV classifications

33910000

Pathology dissection instruments and supplies

Lots

Lot 1 Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients

£660,000

NWSSP Procurement Services intends to award a contract on behalf of Cardiff and Vale University Health Board, AWMGS, for the supply of whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing from CeGAT. The contract is estimated to commence in June 2024, for a period of two years.

Delivery: Cardiff and Vale of Glamorgan

Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients

Not provided

In-line with All Wales Medical genomic Service’s (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testi...

Award notice · Web page

Contains public sector information licensed under the Open Government Licence v3.0.